24.08
Edgewise Therapeutics Inc Borsa (EWTX) Ultime notizie
EWTX SEC FilingsEdgewise Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Edgewise Therapeutics (NASDAQ:EWTX) Trading Down 5.4%Should You Sell? - MarketBeat
XTX Topco Ltd Takes Position in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Sio Capital Management LLC Acquires New Position in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Edgewise Therapeutics Advances with Phase 1 Study of EDG-15400 - MSN
Edgewise Therapeutics reports inducement grants as permitted by the Nasdaq Listing Rules - marketscreener.com
Edgewise Therapeutics (Nasdaq: EWTX) issues inducement option for 26,250 shares at $26.04 - Stock Titan
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Edgewise Therapeutics (EWTX) Stock Analysis Report | Financials & Insights - Benzinga
Geode Capital Management LLC Raises Holdings in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Is Edgewise Therapeutics Inc a good long term investmentHigh Dividend Yield Stocks & High Yield Portfolio Growth - earlytimes.in
[Form 4] Edgewise Therapeutics, Inc. Insider Trading Activity - Stock Titan
Edgewise Therapeutics Appoints Christopher Martin to Board - MSN
Will Edgewise Therapeutics (EWTX) Gain a Commercial Edge With Its New Board Appointment? - Sahm
Edgewise Therapeutics adds commercial biotech exec Martin to board - Investing.com
Edgewise Therapeutics adds commercial biotech exec Martin to board By Investing.com - Investing.com Nigeria
Edgewise Therapeutics Appoints Christopher Martin as Director - TradingView
[8-K] Edgewise Therapeutics, Inc. Reports Material Event | EWTX SEC FilingForm 8-K - Stock Titan
Edgewise Therapeutics appoints commercial biotech executive Christopher Martin to its Board of Directors - marketscreener.com
Edgewise Therapeutics Appoints Commercial Biotech Executive Christopher Martin To Its Board Of Directors - TradingView
Edgewise Therapeutics Appoints Commercial Biotech Executive Christopher Martin to its Board of Directors - WV News
What is the fair value of Edgewise Therapeutics Inc. stock now2025 Market Outlook & Daily Stock Trend Watchlist - newser.com
What recovery options are there for Edgewise Therapeutics Inc.Quarterly Performance Summary & Accurate Trade Setup Notifications - newser.com
Multi asset correlation models including Edgewise Therapeutics Inc.Weekly Trading Summary & Daily Profit Focused Stock Screening - newser.com
Exit strategy if you’re trapped in Edgewise Therapeutics Inc.Earnings Overview Report & Short-Term High Return Ideas - newser.com
How to track smart money flows in Edgewise Therapeutics Inc.July 2025 Breakouts & Safe Entry Point Identification - newser.com
Will Edgewise Therapeutics’ (EWTX) New CFO Mark a Shift in Its Commercial Strategy? - Yahoo Finance
What valuation multiples suggest for Edgewise Therapeutics Inc. stockPrice Action & Free Technical Confirmation Trade Alerts - newser.com
Shareholder Carruthers Files To Sell 70,000 Of Edgewise Therapeutics Inc [EWTX] - TradingView
Order flow analysis tools used on Edgewise Therapeutics Inc.GDP Growth & Weekly Top Gainers Trade List - newser.com
Edgewise Therapeutics chief business officer sells $300,300 in stock - MSN
Edgewise Therapeutics (EWTX) Reports Heightened R&D Activity in Q3 2025 - Insider Monkey
Published on: 2025-11-16 12:13:56 - newser.com
What drives Edgewise Therapeutics Inc stock priceGeopolitical Risk Analysis & Low Cost Capital Trading - earlytimes.in
Risk adjusted return profile for Edgewise Therapeutics Inc. analyzedCEO Change & Technical Confirmation Alerts - newser.com
Real time breakdown of Edgewise Therapeutics Inc. stock performance2025 Market Sentiment & Risk Adjusted Buy and Sell Alerts - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):